Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tumor cell membrane is a dynamic structure critical for cancer cell survival and progression. It is characterized by altered lipid composition, overexpression of specific proteins, and reorganized membrane domains. Secreted phospholipase C (PLC) and other lipases can remodel the membrane and influence signaling pathways. Targeting the tumor cell membrane via these enzymes offers potential therapeutic advantages, including disruption of signaling, induction of immunogenic cell death, and overcoming drug resistance.
Disruption of membrane integrity, alteration of lipid composition, modulation of signaling pathways, induction of immunogenic cell death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell Membrane (via Secreted Phospholipase C/Lipases) (TCM-PLC/Lipases).